Interleukin-12 Antagonist [EPC] - N0000192797

Pharmacologic Class Information

Pharmacologic Code N0000192797
Pharmacologic Name Interleukin-12 Antagonist
Pharmacologic Uses
  • interleukin-12 antagonist
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Interleukin-12 Antagonist

The table contains 40 products whose active ingredient are classified under the same pharmacologic class Interleukin-12 Antagonist [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
51407-929Imuldosa Non-Proprietary Name: Ustekinumab-srlfInjectionSubcutaneousGolden State Medical Supply, Inc.ACTIVE
51407-930Imuldosa Non-Proprietary Name: Ustekinumab-srlfInjectionSubcutaneousGolden State Medical Supply, Inc.ACTIVE
51407-931Imuldosa Non-Proprietary Name: Ustekinumab-srlfInjectionIntravenousGolden State Medical Supply, Inc.ACTIVE
51759-505Selarsdi Non-Proprietary Name: Ustekinumab-aeknInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
51759-607Selarsdi Non-Proprietary Name: Ustekinumab-aeknInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
51759-708Selarsdi Non-Proprietary Name: Ustekinumab-aeknInjection, SolutionIntravenousTeva Pharmaceuticals Usa, Inc.ACTIVE
51759-709Ustekinumab-aekn Non-Proprietary Name: Teva Pharmaceuticals Usa, Inc.
51759-709Ustekinumab-aekn Non-Proprietary Name: Ustekinumab-aeknInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
51759-710Ustekinumab-aekn Non-Proprietary Name: Teva Pharmaceuticals Usa, Inc.
51759-710Ustekinumab-aekn Non-Proprietary Name: Ustekinumab-aeknInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
57894-054Stelara Non-Proprietary Name: UstekinumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-060Stelara Non-Proprietary Name: UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-061Stelara Non-Proprietary Name: UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-440Ustekinumab Non-Proprietary Name: UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-441Ustekinumab Non-Proprietary Name: UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-444Ustekinumab Non-Proprietary Name: UstekinumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
61314-651Pyzchiva Non-Proprietary Name: Ustekinumab-ttweInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-652Pyzchiva Non-Proprietary Name: Ustekinumab-ttweInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-654Pyzchiva Non-Proprietary Name: Ustekinumab-ttweInjection, SolutionIntravenousSandoz IncACTIVE
65219-824Otulfi Non-Proprietary Name: Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-826Otulfi Non-Proprietary Name: Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-828Otulfi Non-Proprietary Name: Ustekinumab-aauzSolutionIntravenousFresenius Kabi Usa, LlcACTIVE
72606-027Steqeyma Non-Proprietary Name: Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Inc.ACTIVE
72606-028Steqeyma Non-Proprietary Name: Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Inc.ACTIVE
72606-029Steqeyma Non-Proprietary Name: Ustekinumab-stbaInjection, SolutionIntravenousCelltrion Inc.ACTIVE
82009-160Ustekinumab-ttwe Non-Proprietary Name: Ustekinumab-ttweInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LlcACTIVE
82009-162Ustekinumab-ttwe Non-Proprietary Name: Ustekinumab-ttweInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LlcACTIVE
82009-163Ustekinumab-ttwe Non-Proprietary Name: Ustekinumab-ttweInjection, SolutionIntravenousQuallent Pharmaceuticals Health LlcACTIVE
83257-023Yesintek Non-Proprietary Name: UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-024Yesintek Non-Proprietary Name: UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-025Yesintek Non-Proprietary Name: UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-026Yesintek Non-Proprietary Name: UstekinumabSolutionIntravenousBiocon Biologics Inc.ACTIVE
83457-651Pyzchiva Non-Proprietary Name: Ustekinumab-ttweInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-652Pyzchiva Non-Proprietary Name: Ustekinumab-ttweInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-654Pyzchiva Non-Proprietary Name: Ustekinumab-ttweInjection, SolutionIntravenousCordavis LimitedACTIVE
84612-055Wezlana Non-Proprietary Name: Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-066Wezlana Non-Proprietary Name: Ustekinumab-auubInjection, SolutionIntravenousOptum Health Solutions (ireland) LimitedACTIVE
84612-076Wezlana Non-Proprietary Name: Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-089Wezlana Non-Proprietary Name: Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-855Wezlana Non-Proprietary Name: Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-876Wezlana Non-Proprietary Name: Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-889Wezlana Non-Proprietary Name: Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE